SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending as community members rally behind the stock, fueled by potential catalysts like a new CEO announcement and optimism around future interest rate cuts. The stock's recent surge has sparked discussions of a potential short squeeze and gamma squeeze, with retail investors expressing strong bullish sentiment. A well-known celebrity recently announced their support of $OPEN adding fuel to the fire.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to a land sale agreement potentially boosting its NAV, attracting attention for its small float and potential for a significant upward move. Community discussions highlight the possibility of a short squeeze, comparing it to other recent low float runners. The stock's low float and increasing volume are key talking points.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as the community anticipates upcoming earnings, speculating on profitability and potential impacts from new ventures like trading cards and the collectibles market. Some traders are weighing the possibility of a Roaring Kitty return, while others debate the stock's long-term prospects and the potential for market manipulation. There's also discussion of a possible Lego partnership and its impact on revenue.

Forward Industries, Inc. engages in the provision of integrated design, development, and manufacturing solutions for top tier medical and technology customers worldwide. It operates through the following segments: OEM Distribution, Retail Distribution, and Design. The OEM Distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices. The Retail Distribution segment sells smart-enabled furniture and a variety of other products through agreements with various retailers, both in stores and through online retailer websites. The Design segment provides hardware and software product design and engineering services. The company was founded in 1961 and is headquartered in Hauppauge, NY.

Forward Industries, Inc.

Forward Industries ($FORD) is trending due to a significant after-hours surge, driven by speculative momentum and social media buzz, despite no clear news catalyst. The community is actively discussing whether this surge is sustainable, with some mistaking it for Ford Motor Company ($F), while others point to its low float and potential for a short squeeze. Overall, Forward Industries is attracting attention as a low-float stock with potential for volatility.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is trending amid speculation of a potential acquisition following leadership changes, with Nestle being a frequently mentioned suitor. Community discussions focus on the possibility of a merger or strategic partnership to bolster the company's finances and pipeline. The stock's high short interest and low float are also fueling hopes for a potential short squeeze.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media (DJT) is trending amid discussions about its connections to political figures, the launch of a Trump-backed stablecoin, and general market volatility. The community is expressing concerns about potential financial risks and ethical considerations, with some questioning the company's fundamentals. Commentary ranges from political accusations to speculation about the stock's future performance.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is trending due to anticipation surrounding its upcoming earnings announcement, which will be unusually presented from the floor of the NYSE, fueling speculation of major news. The community is actively discussing potential partnerships, buyouts, and a positive forward outlook. Investors are also eyeing the company's strong revenue growth and AI capabilities within the burgeoning space economy.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is trending amid discussions about its AI capabilities and potential, with community members debating whether the market is properly valuing its AI narrative. Some are pointing to significant buybacks and undervaluing while others are cautious, citing volatility and the company's AI transition. Overall, conversation is centered on Baidu's potential for growth in the AI sector.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as chatter revolves around a cut in Red Sea cables impacting Azure services, though the company states network traffic remains unaffected. The community is weighing the impact of this disruption alongside broader discussions on AI and upcoming earnings. Some traders are also observing technical patterns, like Elliott Wave sequences and potential pullbacks.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending due to updated data on its lung cancer drug, Ivonescimab, sparking debate about its efficacy, particularly in Western patient subgroups, with some questioning the statistical significance of the results. Community members are actively discussing the implications of this data for potential FDA approval and comparing it to competitor drugs and trials. Additionally, speculation around potential partnerships or a buyout continues to fuel interest in the stock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance  3L

Nationally Established Q Code Will Further Support the Use of Biovance 3L by Physicians to Treat Wound Care Patients in Office SettingsFLORHAM PARK, N.J., March 26, 2024 (GLOBE NEWSWIRE...

Kuehn Law Encourages Investors of Celularity Inc. to Contact Law Firm

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Celularity, Inc. (NASDAQ: CELU) breached...

Celularity submits request to FDA for orphan drug designation for PDA-002

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy

Company Has Already Received IND Clearance from the FDA and Plans to Begin Phase 1/2 Study in 2024 with Off-the-Shelf, Placental-Derived Cell TherapyFLORHAM PARK, N.J., March 20, 2024 (GLOBE...

Celularity CEO to Present on Cell Therapy's Potential to Improve Longevity at 2024 ABUNDANCE Summit

Presentation Will Discuss Cellular Immunotherapy's Potential Role in Treating Chronic Conditions and Extending People's LivesFLORHAM PARK, N.J., March 14, 2024 (GLOBE NEWSWIRE) -- Celularity Inc...

Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress

Keynote Will Discuss Cellular Immunotherapy's Potential for Treating Chronic Conditions, Including Cancer, Multiple Sclerosis and Parkinson's DiseaseFLORHAM PARK, N.J., March 12, 2024 (GLOBE...

Celularity to present in vivo data from T-cell therapy platform at AACR

Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental Cells

Company presenting an in vivo study of PT-CD16, a genetically modified allogeneic cell therapy derived from human placental circulating T (P-T) cells at AACR Annual Meeting 2024FLORHAM PARK, N.J...

Celularity trading halted, news pending

Celularity Stock to Reverse Split on Thursday, February 29th (NASDAQ:CELU)

Celularity Inc. (NASDAQ:CELU  Free Report)s stock is going to reverse split before the market opens on Thursday, February 29th. The 1-10 reverse split was announced on Thursday...

Celularity, Inc. is a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other. The Cell Therapy segment consists of the therapies the company is researching and developing. The BioBanking segment focuses on stem cells from umbilical cords and placentas and provides storage of such cells on behalf of individuals for future use. The Degenerative Disease segment offers products used in surgical and wound care markets. The company was founded by Robert Joseph Hariri Gordon in 2016 and is headquartered in Florham Park, NJ.

Current Price	$2.41
Prev Close	$2.36
Open	$2.34
Dividend Yield	0.00%
50-Day Moving Average	$2.95
Beta	1.57
Avg. Volume	66,434.00
PE Ratio	-0.76

52-Week High	$5.22
52-Week Low	$1.00
Market Capitalization	$57.72M
EPS (Annual)	-$2.64
Price to Book	-2.33
Revenue Per Employee	$440,813.01
Enterprise Value/EBITDA	N/A

CELU
Celularity Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CELU News

CELU Celularity Inc - Ordinary Shares - Class A